The primary objective of the Molecular NMR Shared Facility is to provide NMR instrumentation and expertise for elucidating the structure and dynamic behavior of macromolecules. To achieve this goal, the facility provides training and educational activities for Cancer Center members in their research programs and drug discovery efforts. In addition, the facility provides expertise and technical support in experimental design and sample preparation. The Molecular NMR Shared Facility was one of the original shared facilities established in 1972 by the UAB Comprehensive Cancer Center, and continues to be a mainstay by providing critical, state-of-the-art resources. In just the last year, the NMR Facility has dramatically expanded its cutting-edge research capabilities in support of Cancer Center members. First, a grant to Dr. Rama Krishna from the NCRR High-End Instrumentation Program funded nearly $2 million for the acquisition of a state-of-the-art 800 MHz NMR System equipped with a cryoprobe. This 800 MHz NMR system will be devoted primarily for structural investigations on high-molecular weight systems. The installation of this 800 MHz NMR system is anticipated to be completed during the next few months, following the renovation of the proposed housing area in the Chemistry Building. Second, a state-of-the-art cryoprobe-equipped 700 MHz NMR system in the Chemistry Department has been added to the Cancer Center NMR Facility. This instrument will be devoted primarily for drug discovery and development research projects in the Cancer Center. Third, the existing 600 MHz NMR system was upgraded with a TCI cryoprobe. During the previous funding period, 98% of facility usage was devoted to support Cancer Center members from five different programs. CCC investigators who use the facility are involved in work on the design and synthesis of several novel anticancer drugs (paclitaxel conjugates, curcumin conjugates, nucleoside analogs, new retinoid derivatives active against breast and skin cancers, etc.), metastasis suppressor protein KISS1, protein interactions in cholangiocarcinoma, DNA oligonucleotides that induce TLR-9-mediated metastasis, structural studies on HIV1 proteins, etc. Continued NMR Facility support to these on-going projects as well as several new NCI-funded research projects is proposed during the next five-year period.

Public Health Relevance

NMR is a technology used in research to be able to understand three-dimensional structure at the atomic level in such a way that the dynamics of molecular motion and the interactions of drugs with targets can be accurately measured. This shared facility provides UAB CCC members with the capacity to analyze molecular interactions critical for both understanding basic mechanistic structures and using that information to refine potential therapeutics for cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013148-42
Application #
8738168
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
42
Fiscal Year
2014
Total Cost
$156,754
Indirect Cost
$63,251
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Barrington, David A; Champion, Macie L; Boitano, Teresa K L et al. (2018) Characteristics of African American women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic. Gynecol Oncol 149:337-340
Banerjee, N Sanjib; Wang, Hsu-Kun; Beadle, James R et al. (2018) Evaluation of ODE-Bn-PMEG, an acyclic nucleoside phosphonate prodrug, as an antiviral against productive HPV infection in 3D organotypic epithelial cultures. Antiviral Res 150:164-173
Keene, Kimberly S; King, Tari; Hwang, E Shelley et al. (2018) Molecular determinants of post-mastectomy breast cancer recurrence. NPJ Breast Cancer 4:34
Kleinpeter, Alex B; Jureka, Alexander S; Falahat, Sally M et al. (2018) Structural analyses reveal the mechanism of inhibition of influenza virus NS1 by two antiviral compounds. J Biol Chem 293:14659-14668
Jimenez, Rachel V; Wright, Tyler T; Jones, Nicholas R et al. (2018) C-Reactive Protein Impairs Dendritic Cell Development, Maturation, and Function: Implications for Peripheral Tolerance. Front Immunol 9:372
Engle, Staci E; Antonellis, Patrick J; Whitehouse, Logan S et al. (2018) A CreER mouse to study melanin concentrating hormone signaling in the developing brain. Genesis 56:e23217
Van Arsdale, Anne R; Arend, Rebecca C; Cossio, Maria J et al. (2018) Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma. Cancer Med 7:616-625
Kim, Harrison (2018) Modification of population based arterial input function to incorporate individual variation. Magn Reson Imaging 45:66-71
Leath 3rd, Charles A; Monk, Bradley J (2018) Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years. Gynecol Oncol 150:391-397
Park, Misun; Yoon, Young Sup (2018) Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes. Korean Circ J 48:974-988

Showing the most recent 10 out of 747 publications